MFEC:PA:PA-Lyxor Core MSCI EMU (DR) UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 15.554

Change

-0.04 (-0.28)%

Market Cap

USD 0.48B

Volume

0.05M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.23 (-0.52%)

USD 56.03B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+0.50 (+0.10%)

USD 13.60B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.32 (+0.09%)

USD 11.29B
WRD:PA HSBC MSCI World UCITS ETF

+0.02 (+0.06%)

USD 11.04B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+0.54 (+0.21%)

USD 10.45B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+2.75 (+0.59%)

USD 7.99B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.29 (+0.08%)

USD 7.49B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

+0.11 (+1.66%)

USD 7.42B
HHH:PA HSBC S&P 500 UCITS ETF

+0.05 (+0.09%)

USD 7.22B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

-0.29 (-0.35%)

USD 5.38B

ETFs Containing MFEC:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.92% 92% A 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.92% 91% A- 77% C+
Trailing 12 Months  
Capital Gain 11.95% 82% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.95% 81% B- 77% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.82% 63% D 68% D+
Dividend Return 9.82% 61% D- 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.73% 75% C 87% B+
Risk Adjusted Return 127.07% 97% N/A 96% N/A
Market Capitalization 0.48B 63% D 67% D+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike